Phio Pharmaceuticals Corp.
Nasdaq-listed company. Follow earnings, filings, products, capital and the competitive forces moving the company.
What’s moving Phio Pharmaceuticals Corp. now
Current reporting with the operating signal separated from the noise.
Phio Pharmaceuticals Corp.: Phio Pharmaceuticals Announces Appointment of Dr. R. Todd Plott to the Board of Directors
The story matters when it changes Phio Pharmaceuticals Corp.’s customers, execution, competitive position or capital requirements.
Watch next: confirmation in a company filing, official release or regulator record.Phio Pharmaceuticals Corp.: Phio Pharmaceuticals Announces Participation in the Renmark Financial Communications Live Virtual Non-Deal Roadshow Series
The story matters when it changes Phio Pharmaceuticals Corp.’s customers, execution, competitive position or capital requirements.
Watch next: confirmation in a company filing, official release or regulator record.Phio Pharmaceuticals Corp. Selected as B2i Digital Featured Company
The story matters when it changes Phio Pharmaceuticals Corp.’s customers, execution, competitive position or capital requirements.
Watch next: confirmation in a company filing, official release or regulator record.Latest PHIO filings.
Investor-relevant reports are shown first, followed by the company’s other recent official submissions.
Phio Pharmaceuticals Corp., quarter by quarter.
Results, guidance and earnings coverage are grouped only when the source headline identifies the reporting period.
First quarter
No verified period-specific item in the current feed.
SEARCH Q1 COVERAGE →Second quarter
No verified period-specific item in the current feed.
SEARCH Q2 COVERAGE →Third quarter
No verified period-specific item in the current feed.
SEARCH Q3 COVERAGE →Fourth quarter / full year
No verified period-specific item in the current feed.
SEARCH Q4 COVERAGE →